| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 7.98B | — |
| Operating expense | — | — |
| Net income | 1.70B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LALPATHLAB.NS returned +13.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +28.7% |
| 1 year | +13.4% |
| 5 years | -3.5% |
| 10 years | +272.8% |
| All-time high | ₹2,025.78 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in LALPATHLAB.NS would be worth today ›Yes. Dr. Lal PathLabs Limited paid 4 dividends over the past 12 months. The most recent was ₹5.00 per share on Jul 30, 2026. The dividend yield is 1.06%.
Dr. Lal PathLabs Limited is part of the Healthcare sector.
Dr. Lal PathLabs Limited has a market cap of 314.55B INR, based on the latest quote.
Dr. Lal PathLabs Limited is scheduled to report earnings on Oct 23, 2026.
